Vitalex Biosciences, LLC is a stealth biotech startup currently focused on immunotherapy and diagnostics based on the Mucorales CotH protein, and developing passive vaccines that can be administered to patients with a deadly condition called mucormycosis. Mucormycosis is an infection caused by any of several related molds, causing pain, fever, and sometimes cough and can destroy structures in the face. The firm's principal owner is also a resident researcher at LA Biomed, an incubator of innovation with a global reach and a long time quality reputation of improving.